Biofrontera Inc. (BFRI) Key Statistics & Financial Ratios

Biofrontera Inc. (BFRI) — Price $1.21 — Healthcare — Medical - Pharmaceuticals — NASDAQ

Latest reported results:

Key statistics dashboard for Biofrontera Inc. (BFRI). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Stock Data

Price$1.21
Market Cap$15M
Enterprise Value$18.3M
Beta0.64
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-1.98
Price / Book2.58
P/S0.33
EV/EBITDA-3.26
EV/Sales0.40
EV/FCF-2.31
P/FCF-1.92
Earnings Yield-40.70%
FCF Yield-51.19%
Dividend Yield0.00%

Profitability

Gross Margin84.45%
EBIT Margin-13.52%
EBITDA Margin-12.19%
Operating Margin-9.45%
Net Margin-13.78%
Return on Equity-127.78%
Return on Assets-26.45%
Return on Invested Capital-31.18%
Return on Capital Employed-32.27%

Financial Health

Current Ratio1.18
Quick Ratio1.08
Cash Ratio0.44
Debt / Equity1.26
Debt / Assets31.18%
Net Debt / EBITDA-0.51
Interest Coverage-18.81

Per-Share Data

Revenue per share3.57
Book Value per share0.46
Cash per share0.36
FCF per share-0.61
Tangible Book Value per share0.26
Dividend per share0.00

Related companies: AYTU · COCP · DWTX · EVGN · GELS · IMNN · PRPH

Explore sector: Healthcare · Medical - Pharmaceuticals

More sections of BFRI: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks